» Articles » PMID: 32103028

Characterisation of HIV-1 Molecular Epidemiology in Nigeria: Origin, Diversity, Demography and Geographic Spread

Overview
Journal Sci Rep
Specialty Science
Date 2020 Feb 28
PMID 32103028
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Nigeria has the highest number of AIDS-related deaths in the world. In this study, we characterised the HIV-1 molecular epidemiology by analysing 1442 HIV-1 pol sequences collected 1999-2014 from four geopolitical zones in Nigeria using state-of-the-art maximum-likelihood and Bayesian phylogenetic analyses. The main circulating forms were the circulating recombinant form (CRF) 02_AG (44% of the analysed sequences), CRF43_02G (16%), and subtype G (8%). Twenty-three percent of the sequences represented unique recombinant forms (URFs), whereof 37 (11%) could be grouped into seven potentially novel CRFs. Bayesian phylodynamic analysis suggested that five major Nigerian HIV-1 sub-epidemics were introduced in the 1960s and 1970s, close to the Nigerian Civil War. The analysis also indicated that the number of effective infections decreased in Nigeria after the introduction of free antiretroviral treatment in 2006. Finally, Bayesian phylogeographic analysis suggested gravity-like dynamics in which virus lineages first emerge and expand within large urban centers such as Abuja and Lagos, before migrating towards smaller rural areas. This study provides novel insight into the Nigerian HIV-1 epidemic and may have implications for future HIV-1 prevention strategies in Nigeria and other severely affected countries.

Citing Articles

HIV-1 resistance mutations and genetic diversity among children failing antiretroviral treatment in five healthcare facilities in Benin, West Africa.

Dagba Gbessin E, Tchiakpe E, Keke R, Vidal N, Gomgnimbou M, Sina H PLoS One. 2025; 20(1):e0317882.

PMID: 39879199 PMC: 11778783. DOI: 10.1371/journal.pone.0317882.


Prevalence of Cytopenia and its Correlation with Immunosuppression in Naïve HIV-1 Infected Patients Initiating First-Line Antiretroviral Therapy: A Pilot Study.

Usman A, Balogun O, Shuaib B, Musa B, Yusuf A, Ajayi E Infect Chemother. 2024; 55(4):479-489.

PMID: 38183393 PMC: 10771947. DOI: 10.3947/ic.2023.0080.


The impact of the COVID-19 pandemic on routine HIV care and cervical cancer screening in North-Central Nigeria.

Habila M, Obeng-Kusi M, Ali M, Magaji F, Shambe I, Daru P BMC Womens Health. 2023; 23(1):640.

PMID: 38037005 PMC: 10687784. DOI: 10.1186/s12905-023-02782-6.


Utilization of opportunistic cervical cancer screening in Nigeria.

Habila M, Sagay E, Obeng-Kusi M, Ali M, Magaji F, Shambe I Cancer Causes Control. 2023; 35(1):9-20.

PMID: 37530986 DOI: 10.1007/s10552-023-01764-1.


Characterization of a novel HIV-1 circulating recombinant form, CRF91_cpx, comprising CRF02_AG, G, J, and U, mostly among men who have sex with men.

Topcu C, Georgiou V, Rodosthenous J, Demetriades I, Foley B, Kostrikis L Virulence. 2022; 13(1):1331-1348.

PMID: 35979885 PMC: 9397478. DOI: 10.1080/21505594.2022.2106021.


References
1.
Gottlieb M, Schroff R, Schanker H, Weisman J, Fan P, Wolf R . Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981; 305(24):1425-31. DOI: 10.1056/NEJM198112103052401. View

2.
Palm A, Esbjornsson J, Mansson F, Kvist A, Isberg P, Biague A . Faster progression to AIDS and AIDS-related death among seroincident individuals infected with recombinant HIV-1 A3/CRF02_AG compared with sub-subtype A3. J Infect Dis. 2013; 209(5):721-8. DOI: 10.1093/infdis/jit416. View

3.
Kiwanuka N, Robb M, Laeyendecker O, Kigozi G, Wabwire-Mangen F, Makumbi F . HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda. J Acquir Immune Defic Syndr. 2009; 54(2):180-4. PMC: 2877752. DOI: 10.1097/QAI.0b013e3181c98fc0. View

4.
Baeten J, Chohan B, Lavreys L, Chohan V, McClelland R, Certain L . HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis. 2007; 195(8):1177-80. DOI: 10.1086/512682. View

5.
Senkaali D, Muwonge R, Morgan D, Yirrell D, Whitworth J, Kaleebu P . The relationship between HIV type 1 disease progression and V3 serotype in a rural Ugandan cohort. AIDS Res Hum Retroviruses. 2004; 20(9):932-7. DOI: 10.1089/aid.2004.20.932. View